Question 1

Does Zurcher Kantonalbank (Zurich Cantonalbank) own INBX stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Zurcher Kantonalbank (Zurich Cantonalbank) holds 367 shares of INBX (Inhibrx Biosciences), worth $34,773.

Question 2

How many shares of INBX does Zurcher Kantonalbank (Zurich Cantonalbank) own?

Accepted Answer

As of its Q2 2026 13F, Zurcher Kantonalbank (Zurich Cantonalbank) holds 367 shares of INBX (Inhibrx Biosciences).

Question 3

What is Zurcher Kantonalbank (Zurich Cantonalbank)'s INBX position worth?

Accepted Answer

As of its Q2 2026 13F, Zurcher Kantonalbank (Zurich Cantonalbank)'s INBX position is worth $34,773.

Question 4

Is Zurcher Kantonalbank (Zurich Cantonalbank) buying or selling INBX?

Accepted Answer

In Q2 2026, Zurcher Kantonalbank (Zurich Cantonalbank) increased its INBX position by 173 shares (+89.2%).

Question 5

When did Zurcher Kantonalbank (Zurich Cantonalbank) first buy INBX?

Accepted Answer

Zurcher Kantonalbank (Zurich Cantonalbank) already held INBX in its Q2 2024 13F, the earliest on record, and has listed it in 9 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	367	+89.2%	$34,773	0.0%	$94.75	31
2026-Q1	Decreased	194	-61.0%	$13,043	0.0%	$74.33	0
2025-Q4	Unchanged	498	0.0%	$39,342	0.0%	$77.98	0
2025-Q3	Decreased	498	-32.4%	$16,773	0.0%	$32.31	0
2025-Q2	Decreased	737	-10.6%	$10,517	0.0%	$14.43	0
2025-Q1	Increased	824	+598.3%	$11,528	0.0%	$14.12	19
2024-Q4	Unchanged	118	0.0%	$1,817	0.0%	$15.14	0
2024-Q3	Unchanged	118	0.0%	$1,848	0.0%	$15.52	0